New study links specific E. coli strains to higher cancer incidence rates
Higher rates of certain cancers in countries, such as the UK, may be linked to two particular strains of bacteria. ...
Tag: Vaccine
New immune therapy improves survival and reduces tumor burden in glioblastoma
The Wistar Institute's David B. Weiner, Ph.D. -; Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable ...
Are you falling for fake news? Age and analytical thinking might save you
Discover how age, analytical skills, and ideological leanings impact your ability to detect online misinformation—and why interventions are more critical ...
Study shows RSV’s severe impact on US adults, urging more testing and vaccination
Study uncovers staggering RSV impact on US adults, with ICU admissions and in-hospital deaths notably high—prompting calls for better testing ...
Cleveland Clinic presents new findings on triple-negative breast cancer vaccine
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, ...
Advancing vaccine development through green biotechnology
The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each ...
New consortium launched to combat Mpox outbreak in Africa
University College Dublin (UCD) is leading MpoxVax AFRIVAC, a new €1.3 million international consortium that aims to rapidly deploy technology ...
New computational pipeline revolutionizes personalized cancer vaccine design
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors ...
Global experts gather in Brisbane for scientific meeting dedicated to influenza
More than 1,400 experts have visited Brisbane for the world's only scientific meeting dedicated to influenza. OPTIONS XII for the ...
Long-lived plasma cells fail to establish after COVID mRNA vaccination, limiting long-term antibody response
Researchers discover that COVID-19 mRNA vaccines do not generate long-lasting plasma cells in the bone marrow, shedding light on why ...
